Other OTC - Delayed Quote USD

Ayala Pharmaceuticals, Inc. (ADXS)

0.5400 0.0000 (0.00%)
At close: April 24 at 9:41 AM EDT

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Dr. Ruth Ben Yakar Ph.D. Chief Exec. Officer -- -- 1970
Dr. Stela Gangrenovitch Ph.D. Co-Founder, Chief Scientist Officer and Director -- -- --
Mr. Mark Gengrinovitch LLB Co-Founder, Chief Financial Officer and Director -- -- --

Ayala Pharmaceuticals, Inc.

1007 North Orange Street
4th Floor
Wilmington, DE 19802
United States
857-444-0553 https://www.ayalapharma.com
Sector: 
Healthcare
Industry: 
Biotechnology

Description

Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. The company's lead candidates under development include AL102, an oral gamma secretase inhibitor for desmoid tumors; and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. Ayala Pharmaceuticals, Inc. is based in Wilmington, Delaware.

Corporate Governance

Ayala Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 21, 2024 - May 27, 2024
Ayala Pharmaceuticals, Inc. Earnings Call

Related Tickers

IMNM Immunome, Inc.
14.27
-2.66%
 
XBIO Xenetic Biosciences, Inc.
3.8400
-0.26%
 
ARTL Artelo Biosciences, Inc.
1.3418
+2.43%
 
COCP Cocrystal Pharma, Inc.
1.5559
+1.03%
 
SEEL Seelos Therapeutics, Inc.
0.3010
-7.98%
 
IPCIF Intellipharmaceutics International Inc.
0.0600
0.00%
 
IMUC EOM Pharmaceuticals Holdings, Inc.
0.1979
0.00%
 
SPRC SciSparc Ltd.
1.2100
-1.63%
 
CLGN CollPlant Biotechnologies Ltd.
5.41
+0.37%
 
PCSA Processa Pharmaceuticals, Inc.
1.6200
+1.25%